Travelers Companies Inc
XMUN:PA9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Travelers Companies Inc
XMUN:PA9
|
US |
|
Anheuser-Busch Inbev SA
LSE:0A22
|
BE |
|
A
|
Applied Materials Inc
DUS:AP2
|
US |
|
A
|
Altria Group Inc
DUS:PHM7
|
US |
|
C
|
Central Garden & Pet Co
NASDAQ:CENTA
|
US |
|
Columbia Banking System Inc
NASDAQ:COLB
|
US |
|
S
|
Sumitomo Corp
SWB:SUMA
|
JP |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PA9's stock price target?
Price Target
309.91
EUR
According to Wall Street analysts, the average 1-year price target for
PA9 is 309.91 EUR with a low forecast of 138.57 EUR and a high forecast of 381.58 EUR.
What is the Revenue forecast for Travelers Companies Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 1%.
What is the Net Income forecast for Travelers Companies Inc?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 5 years is -6%.